SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

CATASYS INC (OTCMKTS:CATS), a leading provider of proprietary health management services to employers and health insurers, has announced financial results for the previous quarter ended March 31. As per the reports, it managed to grow at a flat rate of 118% YOY in terms of revenues.

Financial Highlights For March Quarter:

When it comes to new enrollments, CATSYS increased at a growth rate of 67% in the previous quarter compared to 1Q2014. The recognized revenue climbed to $433,000 in 1Q2015 from $199,000 in 1Q2014. The 118% increment in the revenue over a period of 12 months was a new record. The growth in deferred revenue was no different from the recognized revenues. CATSYS’ deferred revenue in the March quarter was $515,000, reasonably more than previous year’s $354,000.

Due to continued growth and above expected revenues, CATSYS ended the first quarter of 2015 with $84,000 worth the cash and cash equivalents. April 2015 was no different from the previous quarter as CATASYS executed a bridge note financing of over $2 million in gross proceeds. The amount was used for working capital purposes and repayment of outstanding indebtedness.

In order to cover wider Medicare Advantage members,CATASYS INC (OTCMKTS:CATS) expanded its Wisconsin program with the help of a national health plan. There are quite a few projects in the pipeline, which are supposed to come out in the next couple of months.

The senior management of the company is delighted to announce these results. According to Rick Anderson, COO & President, the first quarter of 2015 brought a lot of moments to cherish. The company didn’t only register an exponential growth in its OnTrak program, but also posted good financial figures. From now onwards, the primary objective of the firm is to maintain this growth and ensure that it can add value to shareholders in the coming months.

SHARE
Previous articleSabine Oil & Gas Corp (OTCMKTS:SOGC) Considering Asset Sales To Pay Debt
Next articleMusclePharm Corp (OTCMKTS:MSLP) Appoints Three New Independent Directors To Its Board of Directors
Steve Kanaval: Portfolio Manager/Writer/ Market Analyst Steve began his career in the Trading Pits in Chicago making markets at the Chicago Mercantile Exchange (NYSE:CME) the Chicago Board of Trade and the CBOE in the early 80’s. He ran the Morgan Stanley Derivative Prop Trading for the firm specializing in Index Arbitrage. He continued his career as a Trader/Portfolio Manager for multiple Hedge Funds during the Internet Boom of the 90’s managing large portfolios. Steve is known as an expert in MicroCap Technology Stocks and the emerging Digital Currency markets as a Portfolio Manager for his Family Office. Steve has managed portfolio’s in volatile asset classes for 3 decades as a commodity trader, hedge fund manager and digital currency trader and miner. Steve publishes his views on the asset classes in a public forum and has published more than 10,000 articles simplifying these complex and volatile assets for readers. His work is published on multiple sites including Bloomberg, Equities.com, Hacked.com, CryptoCurrencyNews as a paid contributor. His work includes research, journalism and archived video on important market volatility related to stocks, digital currency and other volatile misunderstood asset classes. He offers a humorous, unique insight and the related back stories and drivers for readers interested in volatility and emerging market assets. Full disclosure Steve is long 25 digital currencies and sits on the board of multiple public companies involved in digital currencies, and owns shares in these companies from time to time.